Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
Abstract Objectives The objective is to present a pregnancy complication associated with intravenous drug use, namely, that of red blood cell alloimmunization and hemolytic disease of the fetus and newborn. Methods An observational case series is presented including women with red blood cell alloimm...
Saved in:
Main Authors: | Kara B. Markham (Author), Scott R. Scrape (Author), Mona Prasad (Author), Karen Q. Rossi (Author), Richard W. O'Shaughnessy (Author) |
---|---|
Format: | Book |
Published: |
Thieme Medical Publishers, Inc.,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the presence of clinically significant hemolytic disease of the fetus and newborn due to RhD antibodies in multi-ethnic Suriname
by: R. Zonneveld, et al.
Published: (2016) -
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes
by: Derek P. de Winter, et al.
Published: (2023) -
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
by: Derek P. de Winter, et al.
Published: (2023) -
Anti-M Alloimmunization: Management and Outcome at a Single Institution
by: Bethany Stetson, et al.
Published: (2017) -
Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease
by: Daniel R. Mohan, et al.
Published: (2023)